Abstract
To study of exhaled volatile organic compounds (eVOCs) as diagnostic markers, assessment of the progression of respiratory diseases is becoming more widespread. Due to its noninvasive character, detection of eVOCs with a using real-time proton mass spectrometry of exhaled air (PTR-MS) in patients with cystic fibrosis (CF) seems to be particularly attractive.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Paper Title
Journal
Date
